Nutra Blend's medicated calf feed contained unintended monensin, killing calves and prompting a recall.
What happened
FDA inspected Nutra Blend's licensed medicated feed mill in Mason City, IA, from December 12 through December 16, 2022, after a Reportable Food Registry report about calf illnesses and deaths tied to its medicated cattle feed. Lab tests of a customer sample and a retain sample found unintended monensin in Purina Rangeland Calf Creep 14 B68 Medicated lot #101022, and the farm veterinarian's statement and necropsy reports indicated the calves died from ionophore toxicity. The company recalled the feed on December 7, 2022; FDA also cited CGMP, preventive-control, and reporting failures.
What FDA found
The company did not properly identify and control drugs in the mixing area; operators removed barcode tags from staged micro-ingredients, leaving them unidentified and allowing monensin to be added to the wrong feed.
21 CFR 225.42(b)(4)The company's hazard analysis did not adequately assess the chance that a drug of concern would be added to the wrong batch; it relied on old process history and did not consider the February 2022 process change.
21 CFR 507.33(c)(1)The company did not report the feed to FDA's Reportable Food Registry within 24 hours of determining it was reportable; it filed on December 7, 2022, after learning of the problem in November and receiving lab results on December 2.
Section 417(d)(1)(A) of the FD&C Act (21 U.S.C. 350f(d)(1)(A))The company's hazard analysis did not identify mycotoxin formation in grains at ingredient storage as a known or reasonably foreseeable hazard and evaluate it.
21 CFR 507.33The company did not reanalyze its food safety plan after a significant change in ownership and process flow for weighing and staging micro-ingredients.
21 CFR 507.50(b)(1)
What FDA wants
Within 15 working days of receipt, notify FDA in writing of specific corrective steps, how recurrence will be prevented, and include related documentation. If corrective actions cannot be completed in that time, state the reason and completion timeframe; FDA also asked for evidence that the promised corrections are consistently implemented.
Who should pay attention
- feed mills that stage or hand-add micro-ingredients
- animal feed brands using contract or subsidiary manufacturing
- quality teams handling hazard analyses and Reportable Food Registry reports
This is a summary. Read the original letter on fda.gov.